ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
Dow Jones
42.840,26
1,18%
Euro vs US Dollar
1,0429
-0,02%
Bitcoin
97.623,46
-0,14%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. SciSparc Ltd (SPRC) Börsenkurse

SciSparc Ltd

SciSparc Ltd (SPRC)

NASDAQ
0,2133
-0,0004
(-0,19%)
Geschlossen 21 Dezember 10:00PM
Verzögert um 15 Minuten
0,219
0,0057
(2,67%)
Nach Börsenschluss: 1:47AM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
0,219
Gebot
0,2122
Fragen
0,219
Volumen
610.636
0,2014 Tagesbereich 0,2281
0,201 52-Wochen-Bereich 6,78
Marktkapitalisierung
592,105k
Handelsende
0,2137
Handelsbeginn
0,221
Letzte Trade
500
@
0.219
(formt)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 132.554
VWAP
0,217075
Durchschnittliches Volumen (3 Mio.)
647.753
Ausgegebene Aktien
2.703.674
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,11
Gewinn pro Aktie (EPS)
-1,89
Erlöse
2,88M
Nettogewinn
-5,12M

Über SciSparc Ltd

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The compa... SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
scisparc.com
Hauptsitz
Tel Aviv, Center, Isr
Gegründet
-
SciSparc Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SPRC. The last closing price for SciSparc was US$0,21. Over the last year, SciSparc shares have traded in a share price range of US$ 0,201 to US$ 6,78.

SciSparc currently has 2.703.674 shares in issue. The market capitalisation of SciSparc is US$577.775,13 . SciSparc has a price to earnings ratio (PE ratio) of -0.11.

SPRC Neueste Nachrichten

Weitere Nachrichten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 Dezember 2024
Edgar (US Regulatory)

SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company

According to the LOI, SciSparc’s pharmaceuticals assets are valued at approximately US$11.6 million TEL AVIV, Israel, Dec. 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company”...

16 Dezember 2024
GlobeNewswire Inc.

Form 425 - Prospectuses and communications, business combinations

29 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

29 November 2024
Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations

27 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

27 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

04 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

23 Oktober 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

22 Oktober 2024
Edgar (US Regulatory)

SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment

FDA confirms that SciSparc’s study may proceed only a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or...

30 September 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0369-14.41969519340.25590.28490.2016813310.23363104CS
4-0.0395-15.28046421660.25850.28490.2015744820.23885867CS
12-0.0216-8.977556109730.24060.29750.2016477530.24669651CS
26-0.671-75.3932584270.891.310.20121303010.44388874CS
52-4.881-95.70588235295.16.780.20114408491.31969656CS
156-181.781-99.8796703297182184.080.201154880714.81322873CS
260-181.781-99.8796703297182184.080.201154880714.81322873CS

SPRC - Frequently Asked Questions (FAQ)

What is the current SciSparc share price?
The current share price of SciSparc is US$ 0,219
How many SciSparc shares are in issue?
SciSparc has 2.703.674 shares in issue
What is the market cap of SciSparc?
The market capitalisation of SciSparc is USD 577,78k
What is the 1 year trading range for SciSparc share price?
SciSparc has traded in the range of US$ 0,201 to US$ 6,78 during the past year
What is the PE ratio of SciSparc?
The price to earnings ratio of SciSparc is -0,11
What is the cash to sales ratio of SciSparc?
The cash to sales ratio of SciSparc is 0,2
What is the reporting currency for SciSparc?
SciSparc reports financial results in USD
What is the latest annual turnover for SciSparc?
The latest annual turnover of SciSparc is USD 2,88M
What is the latest annual profit for SciSparc?
The latest annual profit of SciSparc is USD -5,12M
What is the registered address of SciSparc?
The registered address for SciSparc is 20 RAUL WALLENBERG ST., TOWER A, 2ND FLOOR, TEL AVIV, CENTER, 6971916
What is the SciSparc website address?
The website address for SciSparc is scisparc.com
Which industry sector does SciSparc operate in?
SciSparc operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
120,01M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
76,64M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
33,95M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,61k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
120,4M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,33M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
310,19M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
306,25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
293,22M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
281,23M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
SPRC
SciSparc
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten